Skip to content
  • (+61) 2 8203 8741
  • [email protected]
Search
Close
FreshleafAnalytics-logo
  • About Us
    • Our team
  • Services
    • Freshleaf Reports
  • Partners
  • Media
  • News
  • Contact us
Menu
  • About Us
    • Our team
  • Services
    • Freshleaf Reports
  • Partners
  • Media
  • News
  • Contact us
Report H2 2021
Read more about the article 2021 is giving us over-the-counter medical cannabis
2021 is giving us over-the-counter medical cannabis

2021 is giving us over-the-counter medical cannabis

  • Post author:FreshLeaf Analytics
  • Post published:December 22, 2020
  • Post category:Media
  • Post comments:0 Comments

From early 2021 you'll technically be allowed to buy low-dose cannabis oil from pharmacies without a prescription.However, while the laws have been changed so you can buy CBD oil over-the-counter,…

Continue Reading2021 is giving us over-the-counter medical cannabis
FreshleafAnalytics-logo

The team at FreshLeaf Analytics are experts in the medicinal cannabis market in Australia. 

Contact us

  • [email protected]
  • (+61) 2 8203 8741
  • Follow us!
Facebook-f Twitter Linkedin

Get in touch!

© 2022 All rights reserved​, FreshLeaf Analytics

FreshLeaf Analytics H2 2021

The H2 2021 report is FreshLeaf Analytics’ seventh market
report on patients, products and pricing in the Australian
medicinal cannabis market.

Key highlights include:

  • Market growth will exceed expectations in 2021 as active patient numbers surge towards 100,000
  • Revenue from product sales forecast at $230 million at year end
  • Product count continues to climb although the growth rate of new products is slowing
  • Average monthly spend continues its slow downward trend while average daily dose increases
Download Report H2 2021